Business Wire

Kalray and 2CRSi Join Forces and Demonstrate Composability at SuperComputing 2019

Share

Kalray (Paris:ALKAL), pioneer in processors for new intelligent systems, and 2CRSi (Paris:2CRSi), a leader in the design and manufacturing of very high-performance IT servers announce today that companies are leveraging their mutual technology and expertise to build composable and scalable server appliances.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191118005632/en/

Combined expertise for real synergy
Kalray’s reconfigurable acceleration solutions provide the opportunity for 2CRSi to expand its offer for the highly diversified enterprise datacenter market, including Small and Medium Businesses. There is a demanding and evolving need for flexibility, computing performance and fast integration, requiring easy to deploy reconfigurable solutions. With a unique architecture, Kalray’s programmable acceleration cards based on MPPA® (“Massively Parallel Processor Array”) can run real-time and compute-intensive applications on the same card and be seamlessly reconfigured during its lifetime in the field.

Through this collaboration, 2CRSi is strengthening its strategy to rapidly build tailor-made high-performance computing solutions for high-growth domains such as video surveillance, defect detection, finance algorithm optimization, Artificial Intelligence and many others.

One single card – Multiple configurations
Kalray’s MPPA manycore intelligent processor is making the KONIC™ PCIe cards fully programmable and easily reconfigurable, supporting addition, removal, or modification of optimized software modules as required during the lifetime of the card. Such module reconfiguration could include a mix of AI engines, application acceleration or protocol stacks.
Using a standard and open programmable development environment, this brings true composability and flexibility to expert system integrators such as 2CRSi.

Alain Wilmouth, CEO of 2CRSi explained: “2CRSi is always eager to develop innovative technology and provide state-of-the-art solutions. We are very excited to leverage Kalray’s technology. Starting with this demonstration at Supercomputing 2019, we want to further explore what composable and flexible solutions can be built to satisfy our customers. ultimately resulting in an optimized Total Cost of Ownership.”

Éric Baissus, CEO of Kalray commented: “2CRSi is one the most innovative solution providers delivering best in class server solutions in terms of cost, compute and power consumption. We are glad to contribute to 2CRSi’s offering with our KONIC reconfigurable cards and to enable 2CRSi to rapidly build the best solutions for their Customers.”

Demonstration at SuperComputing 2019
2CRSi and Kalray will showcase three different software configurations of the same KONIC™ reconfigurable PCIe card integrated into a dual-x86 server built by 2CRSi:

  • Multiple and heterogenous AI Inference engines (“Multi-CNN”);
  • Flexible multi-acceleration - Example of Fast Fourier Transform (FFT) acceleration;
  • High performance storage disaggregation using Kalray’s Target Controller (“KTC™”) for low latency access to high density JBOF (“Just a Bunch of Flash”).

For more information and to view the demonstrations, come and visit us at SuperComputing,
the international conference for high performance computing, networking, storage, and
Analysis, from November 18 to 21 at Colorado Convention Center, Denver, USA:
Kalray’s booth #2205 and 2CRSi booth #1801

À propos de Kalray
Kalray (Euronext Growth Paris - FR0010722819 - ALKAL) is the pioneer in processors for new intelligent systems. A genuine technological breakthrough, “intelligent” processors are able to intelligently analyze a vast quantity of data on the fly and to make decisions and interact in real time with the outside world. These intelligent processors will be largely deployed in fast-growing sectors such as new-generation networks (intelligent data centers) and autonomous vehicles, as well as in healthcare equipment, drones and robots. Kalray’s offering spans both processors and global solutions (electronic boards and software). Created in 2008 as a spin-off of CEA (“Commissariat à l’Énergie Atomique”, the French Alternative Energies and Atomic Energy Commission), Kalray addresses a broad spectrum of customers including server manufacturers, intelligent system integrators and consumer product manufacturers such as car makers.
Read more at: www.kalrayinc.com

À propos de 2CRSi
2CRSi is headquartered in Strasbourg, France, and has subsidiaries in Manchester, UK, Dubai, UAE, and San Jose in the Silicon Valley. It specializes in the design and manufacturing of very high-performance IT servers. It provides innovative calculation, data storage and data transfer solutions to over 200 various clients in 25 countries.
Read more at: www.2crsi.com

Contact information

CONTACTS FOR KALRAY
INVESTORS
Eric BAISSUS
contactinvestisseurs@kalray.eu
+33 (0)76 18 90 71

ACTUS finance & communication
Caroline LESAGE
kalray@actus.fr
+33 (0)1 53 67 36 79

MEDIA
Loic HAMON
communication@kalray.eu
+33 ()04 76 18 90 71

ACTUS finance & communication
Serena BONI
sboni@actus.fr
+33 (0)4 72 18 04 92

CONTACTS FOR 2CRSi
INVESTORS
Valérie Bouleau
Chief Financial Officer
investors@2crsi.com
+33 (0)3 69 73 81 30

Actifin
Victoire Demeestère
Financial Communication
vdemeestere@actifin.fr
+ 33 (0)1 56 88 11 24

MEDIA
Actifin
Jennifer Jullia
jjullia@actifin.fr
+ 33 (0)1 56 88 11 19

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Avanti Acquisition Corp. Announces Launch of $500,000,000 Initial Public Offering1.10.2020 10:00:00 EESTPress release

Avanti Acquisition Corp. (the “Company”), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, today announced the commencement of its initial public offering of 50,000,000 units at a price of $10.00 per unit. The Company is sponsored by Avanti Acquisition SCSp, an affiliate of NNS Group, the private family office of Nassef Sawiris and Sienna Capital, a subsidiary of Groupe Bruxelles Lambert. The Company intends to be sector agnostic and to focus on European family owned or founder led businesses with a US nexus. The units are expected to be listed on the New York Stock Exchange (the “NYSE”) and trade under the ticker symbol “AVAN.U”. Each unit consists of one share of Class A common stock and one-half of one redeemable warrant. Each whole warrant may be exercised for one share of Class A common stock at a price of $11.50 per share. Only

Castles Technology Announces the Acquisition of Spire Payments1.10.2020 08:59:00 EESTPress release

Castles Technology, one of the top global payment solutions providers which offers services to more than 50 countries around the globe, today announced completion of the acquisition of the business and assets of Spire Payments, the leading European based EFTPOS terminal solutions provider. With the acquisition of the business and assets of Spire Payments, Castles Technology is now even better positioned to deliver market-leading payment solutions that simplify and enhance merchants’ businesses, from in-store acceptance services to value-added solutions. Jean-Philippe Niedergang, Group CCO Castles Technology, says: “I am delighted to welcome Spire Payments’ customers and new colleagues to the Castles Technology family. This acquisition represents an important strategic move for the future of our businesses, as we continue to evolve and innovate to provide merchants acquirers with future-forward payments solutions.” “This acquisition delivers a perfect match between the two companies, wi

BIOCORP Announces Partnership with AARDEX Group to Extend Smart Solutions for Precision Medication Adherence1.10.2020 08:30:00 EESTPress release

Regulatory News: BIOCORP (Paris:ALCOR) (FR0012788065 - ALCOR / Eligible PEA PME), a French company specialized in the design, development and manufacture of innovative medical devices, today announced an alliance with Belgium-based AARDEX Group, the world leader in medication adherence solutions. This alliance is to combine BIOCORP’s connected add-on solutions for drug delivery devices with AARDEX’s proprietary Medication Event Monitoring System (MEMS®) and offer a comprehensive solution to patients and healthcare providers to effectively measure and manage medication adherence. The financial terms of the agreement have not been disclosed, however the first initiative will be to integrate BIOCORP’s Injay connected solution for Pre-filled syringes (PFS) to AARDEX’s MEMS Adherence Software (MEMS AS®), to target medicines delivered by PFS with potential applications in the field of Rheumatoid Arthritis, Multiple Sclerosis, Ophthalmology, Psoriasis or Cardiovascular diseases. The roadmap a

JEOL Strengthens European Business in the Medical Equipment Segment1.10.2020 03:30:00 EESTPress release

JEOL Ltd. (TOKYO:6951) (President & COO Izumi Oi) has opened a new facility in JEOL (EUROPE) B.V. (Zaventem, Belgium) on October 1, 2020, aiming to strengthen the Medical Equipment business in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200930006021/en/ Demo site JEOL (EUROPE) B.V. (Photo: Business Wire) This foundation, with three instruments in operation, not only offers customers the possibility of practical demonstrations and intensive service / application training, but also enables high-quality service and fast logistics from the dedicated warehouse. This new approach is based on a long-term plan that whilst keeping pace with a high standard and matured medical environment in Europe, we will also cover emerging regions such as the Middle East, Eastern Europe and Russia, where the expected growth in economy and population can lead to a steady demand for medical infrastructure. We will continue to promote over

International AI Art Competition Enters Final Round30.9.2020 19:16:00 EESTPress release

Ten finalists have been announced for AI Artathon, the first ever international AI Art competition held in Saudi Arabia. The finalists were revealed during a livestream event to showcase artworks created by the competitors using artificial intelligence tools and techniques. The three winning teams will be announced at the Global AI Summit on 22nd October, where they will share a prize of US$133,000. The AI Artathon is an initiative of the Global AI Summit, to highlight the creative potential of humans and machines working together to create innovative artworks. Twenty teams made up of artists, graphic designers, AI experts and programmers, competed in this stage of the competition, after qualifying during a hackathon held in Riyadh in January. Over 2,000 people from over 50 countries applied to participate in the hackathon, with 300 selected for the three-day event, where teams were formed to develop initial AI art concepts. Twenty teams were selected to take part in a bootcamp, where

VALBIOTIS Publishes Its 2020 Half-Year Results and Provides an Update on Its Global Strategic Partnership with Nestlé Health Science, its strong Financial Visibility and the Promising Advances in Its Pipeline30.9.2020 18:40:00 EESTPress release

Regulatory News: VALBIOTIS (Paris:ALVAL) (FR0013254851 – ALVAL / eligible for the PEA/SME), a Research & Development company committed to scientific innovation for preventing and combating metabolic diseases, announces its results for the first half of 2020 and provides an update on developments since the beginning of the year. Sébastien PELTIER, CEO of VALBIOTIS, commented: "Events in the first half of 2020 have transformed our outlook and helped further boost our international recognition. With the signature of the development and marketing partnership for TOTUM-63 and the launch of the final clinical phase for this Nutrition Healthcare product, entirely financed by Nestlé Health Science, we have demonstrated the soundness of our development model. We are now moving confidently towards marketing and claim submission for TOTUM-63 and, thanks to a solid financial position, we are also working to apply this same model to the rest of our Nutrition Healthcare portfolio. At the head of the

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom